About this Journal Submit a Manuscript Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 463985, 6 pages
http://dx.doi.org/10.1155/2012/463985
Clinical Study

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan

1Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
2Department of Pathology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
3Department of Nuclear Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan

Received 31 March 2012; Accepted 14 June 2012

Academic Editor: Deng-Chyang Wu

Copyright © 2012 Sung-Shuo Kao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Infection with Helicobacter pylori,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 61, pp. 177–240, 1994.
  2. P. Malfertheiner, F. Megraud, C. O'Morain et al., “Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report,” Gut, vol. 56, no. 6, pp. 772–781, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. K. Lam and N. J. Talley, “Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection,” Journal of Gastroenterology and Hepatology, vol. 13, no. 1, pp. 1–12, 1998. View at Scopus
  4. P. I. Hsu, K. H. Lai, C. K. Lin et al., “A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication,” American Journal of Gastroenterology, vol. 100, no. 11, pp. 2387–2392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. J. F. Laheij, L. G. M. Van Rossum, J. B. M. J. Jansen, H. Straatman, and A. L. M. Verbeek, “Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta-analysis,” Alimentary Pharmacology and Therapeutics, vol. 13, no. 7, pp. 857–864, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Y. Graham and L. Fischbach, “Helicobacter pylori treatment in the era of increasing antibiotic resistance,” Gut, vol. 59, no. 8, pp. 1143–1153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Rimbara, L. A. Fischbach, and D. Y. Graham, “Optimal therapy for Helicobacter pylori infections,” Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 2, pp. 79–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Zullo, V. De Francesco, C. Hassan, S. Morini, and D. Vaira, “The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis,” Gut, vol. 56, no. 10, pp. 1353–1357, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. S. Jafri, C. A. Hornung, and C. W. Howden, “Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment,” Annals of Internal Medicine, vol. 148, no. 12, pp. 923–931, 2008. View at Scopus
  10. Y. Gumurdulu, E. Serin, B. Özer et al., “Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey,” World Journal of Gastroenterology, vol. 10, no. 5, pp. 668–671, 2004. View at Scopus
  11. M. A. Bigard, J. C. Delchier, G. Riachi, P. Thibault, and P. Barthelemy, “One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin,” Alimentary Pharmacology and Therapeutics, vol. 12, no. 4, pp. 383–388, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. F. W. Tsay, H. H. Tseng, P. I. Hsu et al., “Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan,” Journal of Gastroenterology and Hepatology, vol. 27, pp. 498–503, 2012.
  13. P. I. Hsu, K. H. Lai, H. H. Tseng et al., “Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia,” Journal of Clinical Gastroenterology, vol. 25, no. 4, pp. 587–591, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Zullo, V. Rinaldi, S. Winn et al., “A new highly effective shout-term therapy schedule for Helicobacter pylori eradication,” Alimentary Pharmacology and Therapeutics, vol. 14, no. 6, pp. 715–718, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Gisbert, X. Calvet, A. O'Connor, F. Mégraud, and C. A. O'Morain, “Sequential therapy for Helicobacter pylori eradication: a critical review,” Journal of Clinical Gastroenterology, vol. 44, no. 5, pp. 313–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Gatta, N. Vakil, G. Leandro, F. Di Mario, and D. Vaira, “Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children,” American Journal of Gastroenterology, vol. 104, no. 12, pp. 3069–3079, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. W. H. Choi, D. I. Park, S. J. Oh et al., “Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea,” The Korean Journal of Gastroenterology, vol. 51, no. 5, pp. 280–284, 2008. View at Scopus
  18. D. Y. Graham and E. Rimbara, “Understanding and appreciating sequential therapy for helicobacterpylori eradication,” Journal of Clinical Gastroenterology, vol. 45, no. 4, pp. 309–313, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Y. Graham, H. Lu, and Y. Yamaoka, “Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond,” Drugs, vol. 68, no. 6, pp. 725–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Essa, J. R. Kramer, D. Y. Graham, and G. Treiber, “Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication,” Helicobacter, vol. 14, no. 2, pp. 109–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. P. Gisbert and X. Calvet, “Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori,” Alimentary Pharmacology and Therapeutics, vol. 34, pp. 604–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Treiber, S. Ammon, E. Schneider, and U. Klotz, “Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication,” Helicobacter, vol. 3, no. 1, pp. 54–58, 1998. View at Scopus
  23. M. Okada, K. Oki, T. Shirotani et al., “A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate,” Journal of Gastroenterology, vol. 33, no. 5, pp. 640–645, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. D. C. Wu, P. I. Hsu, J. Y. Wu et al., “Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection,” Clinical Gastroenterology and Hepatology, vol. 8, no. 1, pp. 36–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. R. Greenberg, G. L. Anderson, D. R. Morgan et al., “14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial,” The Lancet, vol. 378, pp. 507–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. P. I. Hsu, K. H. Lai, E. J. Chien et al., “Impact of bacterial eradication on the cell proliferation and p53 protein accumulation in Helicobacter pylori-associated gastritis,” Anticancer Research, vol. 20, no. 2 B, pp. 1221–1228, 2000. View at Scopus
  27. N. J. Peng, K. H. Lai, R. S. Liu et al., “Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by 13C urea breath test,” Digestive Diseases and Sciences, vol. 46, no. 8, pp. 1772–1778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Kongchayanun, V. Mahachai, B. Pornthisarn, S. Amornsawadwattana, and R. K. Vilaichone, “Efficacy of 10-day and 5-day concomitant therapy for Helicobacter pylori eradication in Thai patients with non ulcer dyspepsia,” Gastroenterology, vol. 140, Supplement 1, p. 879, 2011.
  29. S. Y. Kim, S. W. Lee, B. S. Kwon, et al., “Comparative study of Helicobacter pylori eradication rates of 5-day quadruple ‘Concomitant’therapy and 7-day standard triple therapy.,” Gastroenterology, vol. 140, Supplement 1, p. 878, 2011.
  30. S. Georgopoulos, V. Papastergiou, E. Xirouchakis et al., “Evaluation of a four-drug, three-antibiotic, nonbismuth-containing ‘concomitant’therapy as firstline Helicobacter pylori eradication regimen in Greece,” Helicobacter, vol. 17, no. 1, pp. 49–53, 2012.
  31. T. Suzuki, K. Matsuo, H. Ito et al., “Smoking increases the treatment failure for Helicobacter pylori eradication,” American Journal of Medicine, vol. 119, no. 3, pp. 217–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Midolo and B. J. Marshall, “Accurate diagnosis of Helicobacter pylori: urease tests,” Gastroenterology Clinics of North America, vol. 29, no. 4, pp. 871–878, 2000. View at Publisher · View at Google Scholar · View at Scopus